These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

533 related items for PubMed ID: 11908679

  • 1. Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
    Rogala E, Skopińska-Rózewska E, Sommer E, Pastewka K, Chorostowska-Wynimko J, Sokolnicka I, Kazoń M.
    Anticancer Res; 2001; 21(6B):4259-63. PubMed ID: 11908679
    [Abstract] [Full Text] [Related]

  • 2. A novel in vitro assay for human angiogenesis.
    Brown KJ, Maynes SF, Bezos A, Maguire DJ, Ford MD, Parish CR.
    Lab Invest; 1996 Oct; 75(4):539-55. PubMed ID: 8874385
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK, Halsør EF.
    Cancer Res; 2000 Sep 01; 60(17):4932-8. PubMed ID: 10987309
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Immunohistochemical analysis of expression of angiogenic factors and tumor angiogenesis in superficial bladder cancer].
    Ogura Y, Sato K, Kato T, Saito K, Enomoto K.
    Nihon Hinyokika Gakkai Zasshi; 1998 May 01; 89(5):529-37. PubMed ID: 9642990
    [Abstract] [Full Text] [Related]

  • 6. FGF-2 and FGF-1 expressed in rat bladder carcinoma cells have similar angiogenic potential but different tumorigenic properties in vivo.
    Jouanneau J, Plouet J, Moens G, Thiery JP.
    Oncogene; 1997 Feb 13; 14(6):671-6. PubMed ID: 9038374
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Expression of VEGF and tumor angiogenesis in bladder cancer].
    Wang S, Xia T, Zhang Z, Kong X, Zeng L, Mi P, Xue Z.
    Zhonghua Wai Ke Za Zhi; 2000 Jan 13; 38(1):34-6. PubMed ID: 11831983
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma].
    Guo ZH, Mei H, Huang J, Li SY.
    Ai Zheng; 2003 Mar 13; 22(3):307-9. PubMed ID: 12654193
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regional effects of an antivascular endothelial growth factor receptor monoclonal antibody on receptor phosphorylation and apoptosis in human 253J B-V bladder cancer xenografts.
    Davis DW, Inoue K, Dinney CP, Hicklin DJ, Abbruzzese JL, McConkey DJ.
    Cancer Res; 2004 Jul 01; 64(13):4601-10. PubMed ID: 15231672
    [Abstract] [Full Text] [Related]

  • 13. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F, Azzaro MP, Palumbo G, Bagnato S, Giustolisi G, Floridia P, Sortino G, Giustolisi R.
    Haematologica; 2000 Aug 01; 85(8):800-5. PubMed ID: 10942925
    [Abstract] [Full Text] [Related]

  • 14. Molecular mediators of angiogenesis in bladder cancer.
    Campbell SC, Volpert OV, Ivanovich M, Bouck NP.
    Cancer Res; 1998 Mar 15; 58(6):1298-304. PubMed ID: 9515819
    [Abstract] [Full Text] [Related]

  • 15. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
    Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, Huber J, Nakatani T, Tsujinoue H, Yanase K, Imazu H, Fukui H.
    Hepatology; 2002 Apr 15; 35(4):834-42. PubMed ID: 11915029
    [Abstract] [Full Text] [Related]

  • 16. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
    Inoue K, Slaton JW, Davis DW, Hicklin DJ, McConkey DJ, Karashima T, Radinsky R, Dinney CP.
    Clin Cancer Res; 2000 Jul 15; 6(7):2635-43. PubMed ID: 10914704
    [Abstract] [Full Text] [Related]

  • 17. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T, Schlott T, Korabiowska M, Käthei N, Zöller G, Glaser F, Kunze E.
    Anticancer Res; 2004 Jul 15; 24(5A):2745-56. PubMed ID: 15517881
    [Abstract] [Full Text] [Related]

  • 18. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder.
    Chikazawa M, Inoue K, Fukata S, Karashima T, Shuin T.
    Pathobiology; 2008 Jul 15; 75(6):335-45. PubMed ID: 19096229
    [Abstract] [Full Text] [Related]

  • 19. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, Enamorado I, Yeh NT, Kroog GS, Rudy S, McCullagh L, Mousa S, Quezado M, Herscher LL, Van Waes C.
    Clin Cancer Res; 1999 Jun 15; 5(6):1369-79. PubMed ID: 10389921
    [Abstract] [Full Text] [Related]

  • 20. Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation.
    Howdieshell TR, Callaway D, Webb WL, Gaines MD, Procter CD, Sathyanarayana, Pollock JS, Brock TL, McNeil PL.
    J Surg Res; 2001 Apr 15; 96(2):173-82. PubMed ID: 11266270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.